CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026

ConferenceNeutral
AI Analysis

Summary

Immunic announced it will host a virtual R&D day on September 9, 2026, focused on relapsing multiple sclerosis research and development initiatives.

Importance:2/10
Sentiment:
0.00
R&D_daymultiple_sclerosisoral_therapiesneurologic_diseases
Related Companies

Read the original article

Published by PR Newswire Biotech on September 2, 2026 10:30 AM

Read Original